Literature DB >> 18198895

Development of an on-line SPE-LC-ESI-MS method for urinary nucleosides: hyphenation of aprotic boronic acid chromatography with hydrophilic interaction LC-ESI-MS.

Robin Tuytten1, Filip Lemière, Walter Van Dongen, Erwin Witters, Eddy L Esmans, Russell P Newton, Ed Dudley.   

Abstract

The development of an on-line automated SPE-HPLC--ESI-MS method is described for targeted metabolomic analysis of urinary modified nucleoside levels. The setup comprises a boronate affinity column as a trapping device, a hydrophilic interaction chromatography (HILIC) separation and information-dependent MS detection modes. The system was optimized using standards and tested on biological samples, detecting a number of modified nucleosides. Other urinary biomarkers could also be analyzed by the system developed: for example, the urinary nucleobases were also available for analysis. A simultaneous creatinine-monitoring experiment was also demonstrated to be viable when utilizing the method, which is of benefit as creatinine is a urinary normalizing factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18198895     DOI: 10.1021/ac702057u

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  11 in total

Review 1.  Considerations on HILIC and polar organic solvent-based separations: use of cyclodextrin and macrocyclic glycopetide stationary phases.

Authors:  Chunlei Wang; Chunxia Jiang; Daniel W Armstrong
Journal:  J Sep Sci       Date:  2008-06       Impact factor: 3.645

Review 2.  Recent technical and biological development in the analysis of biomarker N-deoxyguanosine-C8-4-aminobiphenyl.

Authors:  Zhidan Chen; Yuesheng Zhang; Paul Vouros
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-04-24       Impact factor: 3.205

Review 3.  Mass spectrometry of structurally modified DNA.

Authors:  Natalia Tretyakova; Peter W Villalta; Srikanth Kotapati
Journal:  Chem Rev       Date:  2013-02-26       Impact factor: 60.622

Review 4.  Quantitation of DNA adducts by stable isotope dilution mass spectrometry.

Authors:  Natalia Tretyakova; Melissa Goggin; Dewakar Sangaraju; Gregory Janis
Journal:  Chem Res Toxicol       Date:  2012-08-28       Impact factor: 3.739

5.  Permethylation of Ribonucleosides Provides Enhanced Mass Spectrometry Quantification of Post-Transcriptional RNA Modifications.

Authors:  Yixuan Xie; Kevin A Janssen; Alessandro Scacchetti; Elizabeth G Porter; Zongtao Lin; Roberto Bonasio; Benjamin A Garcia
Journal:  Anal Chem       Date:  2022-05-12       Impact factor: 8.008

Review 6.  The multifaceted roles of mass spectrometric analysis in nucleic acids drug discovery and development.

Authors:  Thomas Kenderdine; Dan Fabris
Journal:  Mass Spectrom Rev       Date:  2021-12-23       Impact factor: 9.011

7.  A Platform for Discovery and Quantification of Modified Ribonucleosides in RNA: Application to Stress-Induced Reprogramming of tRNA Modifications.

Authors:  Weiling Maggie Cai; Yok Hian Chionh; Fabian Hia; Chen Gu; Stefanie Kellner; Megan E McBee; Chee Sheng Ng; Yan Ling Joy Pang; Erin G Prestwich; Kok Seong Lim; I Ramesh Babu; Thomas J Begley; Peter C Dedon
Journal:  Methods Enzymol       Date:  2015-07-17       Impact factor: 1.600

Review 8.  The state-of-the-art determination of urinary nucleosides using chromatographic techniques "hyphenated" with advanced bioinformatic methods.

Authors:  Wiktoria Struck; Małgorzata Waszczuk-Jankowska; Roman Kaliszan; Michał J Markuszewski
Journal:  Anal Bioanal Chem       Date:  2011-02-27       Impact factor: 4.142

Review 9.  The identification and characterization of non-coding and coding RNAs and their modified nucleosides by mass spectrometry.

Authors:  Kirk W Gaston; Patrick A Limbach
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

Review 10.  'Borono-lectin' based engineering as a versatile platform for biomedical applications.

Authors:  Akira Matsumoto; Yuji Miyahara
Journal:  Sci Technol Adv Mater       Date:  2017-12-19       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.